Labelling requirements for non-prescription drugs guidance document (English, HTML)

View metadata and access the original English HTML file: Labelling requirements for non-prescription drugs guidance document.

Format

HTML

Access

file-only

Publisher-reported update

2021-07-07

The safe use of non-prescription drugs depends on consumers being able to identify the desired product and also being able to understand and act upon the information presented. The label and package are the first points of interaction between a health product and a consumer or healthcare professional. Prior to the implementation of the Plain Language Labelling (PLL) initiative, the general practice in Canada was to present key information within blocks of text on the product label. This guidance document provides prescriptive information on the design specifications, required sections of the CDFT, and labelling content.

Access original file